Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/d26d60f2-b3ee-4ed5-9030-bc7c365624e7/
SABS
SAB Biotherapeutics IncSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 1.59
V
Value Analysis
Cheapness relative to fundamentals
40.0%ile
P/B
0.8×
FCF Yield
-0.306
EBITDA/EV
0.011
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
61.00000000
/100 — 1=cheapest
VC2 (Trending Value)
61.00000000
/100
VC3 (Buyback)
61.00000000
/100
Negative FCF yield (-30.6%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
39.0%ile
ROE
-0.002
ROA
-0.002
GPA
-0.012
D/E
0.09
Current
11.45
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
4.757
lower=better
Accruals
0.205
lower=better
5yr Consist
No
Conservative balance sheet with D/E of 0.09. Accruals ratio of 0.205 is elevated — earnings quality may be lower than headline numbers suggest.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
39.0%ile
6M Return
-15.1%
12M Return
86.7%
12-1 Mom
127.1%
Risk-Adj
1.59
Vol 252d
79.7%
Vol 60d
147.4%
↑ Expanding
Max DD 12M
-23.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 127% is very strong — a clear uptrend. Risk-adjusted momentum of 1.59 is excellent — strong returns relative to volatility. Near-term vol (147%) is expanding vs long-term (80%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.3
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
10.0%
Sector Quality %ile
10.2%
P/B z-score
-0.35
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Volatility Expanding
60-day vol (147%) significantly exceeds 252-day (80%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
28.1% avg (4 factors)
Quality
D
32.9% avg (6 factors)
Momentum
B
70.9% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.300 | —1 | — | |
| Value %ile | 0.400 | —0 | — | |
| Quality %ile | 0.390 | —0 | — | |
| Momentum %ile | 0.390 | —0 | — | |
| F-Score | 3.000 | —1 | — | |
| Confidence | 0.727 | —1 | — | |
| Volatility | 0.797 | —1 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
0.80
FCF Yield
-30.6%
EBITDA / EV
1.1%
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-0.2%
Return on Assets
-0.2%
Gross Profit / Assets
Novy-Marx GPA
-1.2%
Debt / Equity
0.09
Current Ratio
11.45
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.205
MomentumPrice trend strength over different horizons
6M Return
-15.1%
12M Return
86.7%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
127.1%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.59
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
4.757
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
61
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
61
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
61
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity